
Discovery and development of small molecule therapeutics targeting protein misfolding diseases11-50 Employees
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
- Valuation $500M+This company has a valuation of $500M or more